Want to see HK:8603 full AI Analyst Report?
8603 Stock Chart & Stats
HK$4.30
-HK$0.01(-1.56%)
At close: 4:00 PM EST
HK$4.30
-HK$0.01(-1.56%)
Day’s Range― - ―
52-Week RangeHK$1.24 - HK$19.50
Previous CloseN/A
Volume120.00K
Average Volume (3M)238.30K
Market Cap
HK$13.35B
Enterprise ValueHK$9.25B
Total Cash (Recent Filing)HK$110.69M
Total Debt (Recent Filing)HK$119.18M
Price to Earnings (P/E)114.3
Beta0.31
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding818,920,000
10 Day Avg. Volume318,900
30 Day Avg. Volume238,300
Financial Highlights & Ratios
PEG Ratio4.90
Price to Book (P/B)23.98
Price to Sales (P/S)8.42
P/FCF Ratio110.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth (2023–2026)Sustained top-line expansion from 2023–2026 indicates expanding market penetration and product adoption. Durable revenue growth supports scale economics, funds reinvestment in marketing and R&D, and provides a stable base to sustain margins and cash generation over the medium term.
Healthy Trailing MarginsTTM gross (~37%) and net (~9%) margins show the business is operating profitably after earlier losses. Sustained margins provide a structural cushion to fund growth, service debt and generate free cash flow, supporting long-term financial flexibility and reinvestment capacity.
Improved Leverage And Positive FCFMaterial reduction in leverage versus prior years and positive free cash flow reflect stronger financial resilience. A more manageable debt profile and improving cash generation reduce refinancing risk and give management durable capacity to invest, pay down debt, or weather downturns.
Bears Say
Margin Compression Vs Prior YearsMeaningful margin compression relative to 2023–2025 suggests rising cost pressures or adverse product mix as the company scales. If structural cost inflation or mix shifts persist, they could erode profitability, reduce free cash flow and impair the company’s ability to sustain investments and debt reduction.
Weak Cash Conversion (FCF ~40% NI)Free cash flow at roughly 40% of net income indicates earnings are not fully converting to cash, likely due to working capital or reinvestment needs. Persistently weak cash conversion constrains balance sheet repair, limits organic funding for growth and raises sensitivity to profit shocks.
Historic Volatile, High LeverageA prior history of very high leverage and thin equity signals a volatile capital structure that can reassert under stress. This legacy increases refinancing and solvency risk if margins or cash flow deteriorate, making long-term credit flexibility more fragile than peers.
8603 FAQ
What was Fameglow Holdings Limited’s price range in the past 12 months?
Fameglow Holdings Limited lowest stock price was HK$1.24 and its highest was HK$19.50 in the past 12 months.
What is Fameglow Holdings Limited’s market cap?
Fameglow Holdings Limited’s market cap is HK$13.35B.
When is Fameglow Holdings Limited’s upcoming earnings report date?
Fameglow Holdings Limited’s upcoming earnings report date is Nov 17, 2026 which is in 125 days.
How were Fameglow Holdings Limited’s earnings last quarter?
Fameglow Holdings Limited released its earnings results on May 15, 2026. The company reported HK$0.042 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.042.
Is Fameglow Holdings Limited overvalued?
According to Wall Street analysts Fameglow Holdings Limited’s price is currently Overvalued.
Does Fameglow Holdings Limited pay dividends?
Fameglow Holdings Limited does not currently pay dividends.
What is Fameglow Holdings Limited’s EPS estimate?
Fameglow Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fameglow Holdings Limited have?
Fameglow Holdings Limited has 818,920,000 shares outstanding.
What happened to Fameglow Holdings Limited’s price movement after its last earnings report?
Fameglow Holdings Limited reported an EPS of HK$0.042 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.193%.
Which hedge fund is a major shareholder of Fameglow Holdings Limited?
Currently, no hedge funds are holding shares in HK:8603
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fameglow Holdings Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
391.17%
12-Months-Change
Fundamentals
Return on Equity
72.20%
Trailing 12-Months
Asset Growth
38.54%
Trailing 12-Months
Company Description
Fameglow Holdings Limited
Fameglow Holdings Limited, an investment holding entity, offers a range of non-surgical medical aesthetic services across Hong Kong. These include energy-based procedures, which employ various devices that emit energy onto the skin's surface, and minimally invasive treatments such as injections, characterized by minimal tissue penetration without surgical incisions. The company also provides traditional non-medical and non-invasive beauty services. Additionally, Fameglow sells skincare products through its retail outlets and sales counters, and holds property investments. Its medical aesthetic centers operate under the "per Face" brand, situated in prominent locations like Causeway Bay, Mong Kok, Tsim Sha Tsui, and Central. Founded in 2008, the company is headquartered in Cheung Sha Wan, Hong Kong, and functions as a subsidiary of Equal Joy Holdings Limited.
Technical Analysis
Modern Healthcare Technology Holdings Limited
―
Anxian Yuan China Holdings Limited
―
Perfect Medical Health Management Limited
―
Sino-Life Group Limited
―
Shenghui Cleanness Group Holdings Limited
―